Nektar Therapeutics Says Sandra Gardiner To Retire As Interim CFO, Appoints Linda Rubinstein As Interim CFO, Effective May 15, 2026
Nektar Therapeutics
Nektar Therapeutics NKTR | 0.00 |
Nektar Therapeutics Says Sandra Gardiner To Retire As Interim CFO, Appoints Linda Rubinstein As Interim CFO, Effective May 15, 2026
